Forecast 2023
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
Forecast 2030
TopGraphs Quality Ranking
Underperform
Company Info
P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
1.57
Market Cap
0.82B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Industry
Country
Website
Janux Therapeutics Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Janux Therapeutics Stock Forecast 2023
$29.00
In the last five quarters, Janux Therapeutics’s Price Target has risen from $0.00 to $12.07 - a 100% increase. Zero analysts predict that Janux Therapeutics’s share price will increase in the coming year, reaching $29.00. This would represent an increase of 140.27%.
140.27%
Highest Price Target $35.00
Average Price Target $29.00
Lowest Price Target $25.00
Janux Therapeutics Stock Predictions 2025
Janux Therapeutics Stock Prediction 2030
P/E Ratio
0.0
Beta
0.00
Price-to-book Ratio
1.57
Market Cap
0.82B
TEV
N/A
LT Debt/Cap
N/A
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$0.00
Industry
Country
Website
Janux Therapeutics Analyst Ratings Frequently Asked Questions
Who are the analysts watching Janux Therapeutics, Inc.?
The following analysts have recently covered Janux Therapeutics:
BofA Global Research
Cowen and Company
Evercore ISI
H.C. Wainwright & Co.
(This information refers to the last 90 days.)
Who are the sell-side analysts watching Janux Therapeutics, Inc.?
The following sell-side analysts have recently covered Janux Therapeutics:
Meacham, Geoffrey Christopher
Frahm, Marc Alan
Schimmer, Joshua Elliott
Ramakanth, Swayampakula
(This information refers to the last 90 days.)
